These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22406436)

  • 1. Validation of a Gyrolab™ assay for quantification of rituximab in human serum.
    Liu XF; Wang X; Weaver RJ; Calliste L; Xia C; He YJ; Chen L
    J Pharmacol Toxicol Methods; 2012; 65(3):107-14. PubMed ID: 22406436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gyrolab™ immunoassay system: a platform for automated bioanalysis and rapid sample turnaround.
    Fraley KJ; Abberley L; Hottenstein CS; Ulicne JJ; Citerone DR; Szapacs ME
    Bioanalysis; 2013 Jul; 5(14):1765-74. PubMed ID: 23862708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects.
    Hampson G; Ward TH; Cummings J; Bayne M; Tutt AL; Cragg MS; Dive C; Illidge TM
    J Immunol Methods; 2010 Aug; 360(1-2):30-8. PubMed ID: 20547164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis.
    Roman J; Qiu J; Dornadula G; Hamuro L; Bakhtiar R; Verch T
    J Pharmacol Toxicol Methods; 2011; 63(3):227-35. PubMed ID: 21147239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an alpha fetoprotein immunoassay using Gyros technology.
    Given AM; Whalen PM; O'Brien PJ; Ray CA
    J Pharm Biomed Anal; 2012 May; 64-65():8-15. PubMed ID: 22386211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.
    Liu R; Hoffpauir B; Chilewski SD; Gamberdella J; Kavita U; Duo J; Gleason C; Zhang Y; Pillutla R; DeSilva B; Hamuro L
    AAPS J; 2017 Jan; 19(1):82-91. PubMed ID: 27796911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagents.
    Jordan G; Moheysen-Zadeh M; Heinrich J; Staack RF
    Bioanalysis; 2016 Apr; 8(8):807-14. PubMed ID: 26975340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
    Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
    J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
    Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
    J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An automated nanoparticle-based homogeneous immunoassay for determining docetaxel concentrations in plasma.
    Cline DJ; Zhang H; Lundell GD; Harney RL; Riaz HK; Jarrah J; Li Y; Miyazaki M; Courtney JB; Baburina I; Salamone SJ
    Ther Drug Monit; 2013 Dec; 35(6):803-8. PubMed ID: 24263639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody.
    Liao K; Sikkema D; Wang C; Chen K; DeWall S; Lee TN
    J Immunol Methods; 2012 Jan; 375(1-2):258-63. PubMed ID: 22001556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.
    Siebert N; Seidel D; Eger C; Brackrock D; Reker D; Schmidt M; Lode HN
    J Immunol Methods; 2013 Dec; 398-399():51-9. PubMed ID: 24055592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing matrix effects in ligand-binding assays through the use of new reagents and technology.
    Chilewski SD; Mora JR; Gleason C; DeSilva B
    Bioanalysis; 2014 Apr; 6(8):1059-67. PubMed ID: 24830890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Singlicate Ligand Binding Assay Using an Automated Microfluidic System: a Clinical Case Study.
    Jiang H; Kozhich A; Cummings J; Gambardella J; Zambito F; Titsch C; Haulenbeek J; Phillips K; Fergus R; Myler H
    AAPS J; 2017 Sep; 19(5):1461-1468. PubMed ID: 28589510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
    St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
    J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFalpha antibody in human serum.
    Horninger D; Eirikis E; Pendley C; Giles-Komar J; Davis HM; Miller BE
    J Pharm Biomed Anal; 2005 Jul; 38(4):703-8. PubMed ID: 15967298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum.
    Lowe J; Wakshull E; Shek T; Chuntharapai A; Elliott R; Rusit J; Maia M
    J Immunol Methods; 2018 Oct; 461():44-52. PubMed ID: 29772250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.